{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:26:09Z","timestamp":1760300769293},"reference-count":23,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,12]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>Inflammatory granulomas (neurocysticercosis [NCC] and tuberculomas) are important causes of seizures in children and adults in the developing world. Although several studies have explored seizure characteristics individually in patients with either NCC or tuberculoma, none has compared the seizure recurrence rate between them. This study included patients aged 5 to 18 years with viable parenchymal NCC or tuberculomas who had completed regular follow-up of at least 12 months at a tertiary institute in India. Their baseline seizure and electroencephalographic characteristics, antiseizure medications (ASMs), and breakthrough seizure rates at 12, 24, and 52 weeks were noted. A total of 103 and 54 patients with active NCC and tuberculomas respectively were included. The number of patients who had at least one breakthrough seizure at 12, 24, and 52 weeks in both groups was comparable (<jats:italic>P<\/jats:italic> = 0.32, 0.27, and 0.13), and the vast majority were controlled on monotherapy (98% cases in each group). The proportion of patients who required an increase in the dose or change of ASMs or polytherapy, the proportion of children who had status epilepticus at or before 12 months, abnormal electroencephalogram at 12 months, and calcified and active granuloma in neuroimaging at 12 months were also comparable between the two groups (<jats:italic>P<\/jats:italic> &gt; 0.05 for all). The number of patients who had ASM-related adverse events and discontinued ASM due to serious adverse events was comparable between both groups, except for hepatotoxicity in the tuberculoma group. The predictors for breakthrough seizures that were found to be statistically significant in the NCC group were the presence of perilesional edema in the baseline magnetic resonance imaging (<jats:italic>P<\/jats:italic> = 0.02) and more than five active granulomas (<jats:italic>P<\/jats:italic> = 0.01); predictors in the tuberculoma group were the presence of severe perilesional edema causing midline shift in the baseline magnetic resonance imaging (<jats:italic>P<\/jats:italic> = 0.01) and more than five active granulomas (<jats:italic>P<\/jats:italic> = 0.04). The recurrence rates of breakthrough seizures over the next 12 months in newly detected cases of active NCC and tuberculomas were comparable.<\/jats:p>","DOI":"10.4269\/ajtmh.21-1298","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T13:26:34Z","timestamp":1661779594000},"page":"833-840","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Seizure Characteristics and Recurrence Rates in Children with Viable Parenchymal Neurocysticercosis and Tuberculoma in India"],"prefix":"10.4269","volume":"107","author":[{"given":"Prateek Kumar","family":"Panda","sequence":"first","affiliation":[{"name":"Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Department of Neurology, IQRAA International Hospital & Research Centre, Kozhikode, Kerala, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indar Kumar","family":"Sharawat","sequence":"additional","affiliation":[{"name":"Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Sherwani","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis and Imaging, All India Institute of Medical Sciences, Rishikesh, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowneet Kumar","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Expert Rev Anti Infect Ther","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1586\/eri.12.35","article-title":"Solitary cysticercus granuloma","volume":"10","author":"Garg","year":"2012"},{"key":"b2","series-title":"Sci Rep","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1038\/s41598-021-86823-w","article-title":"Neurocysticercosis in patients with active epilepsy in the tea garden community of Assam, northeast India","volume":"11","author":"Devi","year":"2021"},{"key":"b3","series-title":"J Clin Neurosci Off J Neurosurg Soc Australas","first-page":"1333","article-title":"Tuberculoma of the central nervous system","volume":"20","author":"DeLance","year":"2013"},{"key":"b4","series-title":"Br Med Bull","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldv003","article-title":"Tuberculous meningitis: advances in diagnosis and treatment","volume":"113","author":"T\u00f6r\u00f6k","year":"2015"},{"key":"b5","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014"},{"key":"b6","series-title":"Indian Pediatr","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s13312-021-2311-6","article-title":"Management of neurocysticercosis in children: association of child neurology consensus guidelines","volume":"58","author":"Sankhyan","year":"2021"},{"key":"b7","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e2692","DOI":"10.1371\/journal.pntd.0002692","article-title":"Neurocysticercosis as a cause of epilepsy and seizures in two community-based studies in a cysticercosis-endemic region in Peru","volume":"8","author":"Moyano","year":"2014"},{"key":"b8","series-title":"Pathog Glob Health","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1179\/2047773212Y.0000000026","article-title":"Edema surrounding calcified intracranial cysticerci: clinical manifestations, natural history, and treatment","volume":"106","author":"Nash","year":"2012"},{"key":"b9","series-title":"Infect Dis Poverty","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40249-017-0245-y","article-title":"The causal relationship between neurocysticercosis infection and the development of epilepsy\u2014a systematic review","volume":"6","author":"Gripper","year":"2017"},{"key":"b10","series-title":"Epilepsy Res","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.eplepsyres.2018.10.005","article-title":"Seizures in tuberculous meningitis","volume":"148","author":"Misra","year":"2018"},{"key":"b11","series-title":"Br Med Bull","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldv003","article-title":"Tuberculous meningitis: advances in diagnosis and treatment","volume":"113","author":"T\u00f6r\u00f6k","year":"2015"},{"key":"b12","series-title":"Indian J Med Res","first-page":"448","article-title":"Index-TB guidelines: guidelines on extrapulmonary tuberculosis for India","volume":"145","author":"Sharma","year":"2017"},{"key":"b13","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4269\/ajtmh.18-88751","article-title":"Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"98","author":"White","year":"2018"},{"key":"b14","series-title":"Br J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006"},{"key":"b15","series-title":"J Infect","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jinf.2018.06.009","article-title":"Fluoroquinolones in the management of tuberculous meningitis: systematic review and meta-analysis","volume":"77","author":"Rizvi","year":"2018"},{"key":"b16","series-title":"Epileptic Disord Int Epilepsy J Videotape","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1684\/epd.2012.0516","article-title":"Seizure heralding tuberculous meningitis","volume":"14","author":"Brigo","year":"2012"},{"key":"b17","series-title":"Acta Epileptol","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42494-020-0010-x","article-title":"The prevalence, characteristics and outcome of seizure in tuberculous meningitis","volume":"2","author":"Abdulaziz","year":"2020"},{"key":"b18","series-title":"J Trop Pediatr","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/tropej\/42.2.91","article-title":"Convulsions in tuberculous meningitis","volume":"42","author":"Patwari","year":"1996"},{"key":"b19","series-title":"Int J Infect Dis","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijid.2020.02.007","article-title":"New-onset seizures in adults with tuberculous meningitis during long-term follow-up: characteristics, functional outcomes and risk factors","volume":"93","author":"Song","year":"2020"},{"key":"b20","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4269\/ajtmh.19-0485","article-title":"Unique characteristics of epilepsy development in neurocysticercosis","volume":"103","author":"Herrick","year":"2020"},{"key":"b21","series-title":"Epilepsy Res","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eplepsyres.2017.09.010","article-title":"Clinical and neuroimaging predictors of seizure recurrence in solitary calcified neurocysticercosis: a prospective observational study","volume":"137","author":"Singh","year":"2017"},{"key":"b22","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4269\/ajtmh.19-0278","article-title":"An ambispective cohort study to assess seizure recurrences in children with calcified parenchymal neurocysticercosis","volume":"101","author":"Modak","year":"2019"},{"key":"b23","series-title":"J Trop Pediatr","doi-asserted-by":"publisher","first-page":"fmac032","DOI":"10.1093\/tropej\/fmac032","article-title":"Comparative efficacy and safety of lacosamide and oxcarbazepine for seizure control in children with newly diagnosed solitary neurocysticercosis","volume":"68","author":"Sharawat","year":"2022"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/4\/article-p833.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/4\/article-p833.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/4\/article-p833.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:08:22Z","timestamp":1665590902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/4\/article-p833.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":23,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.21-1298","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]}}}